Related references
Note: Only part of the references are listed.Protein kinase B/AKT mediates insulin-like growth factor 1-induced phosphorylation and nuclear export of histone deacetylase 5 via NADPH oxidase 4 activation in vascular smooth muscle cells
Paulina Pietruczuk et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Involvement of the Akt-dependent CREB signaling pathway in hydrogen-peroxide-induced early growth response protein-1 expression in rat vascular smooth muscle cells
Vincent Rondeau et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2019)
Renin-Angiotensin System and Cardiovascular Functions
Chia-Hua Wu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
ANGIOTENSIN II SIGNAL TRANSDUCTION: AN UPDATE ON MECHANISMS OF PHYSIOLOGY AND PATHOPHYSIOLOGY
Steven J. Forrester et al.
PHYSIOLOGICAL REVIEWS (2018)
Natriuretic peptide receptor-C-mediated attenuation of vascular smooth muscle cell hypertrophy involves Gqα/PLCβ1 proteins and ROS-associated signaling
Ashish Jain et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2018)
STIM-1 and ORAI-1 channel mediate angiotensin-II-induced expression of Egr-1 in vascular smooth muscle cells
Estelle R. Simo-Cheyou et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2017)
cAMP attenuates angiotensin-II-induced Egr-1 expression via PKA-dependent signaling pathway in vascular smooth muscle cells
Estelle R. Simo-Cheyou et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2017)
Early Growth Response Protein-1 Expression by Insulin-Like Growth Factor-1 Requires ROS-Dependent Activation of ERK1/2 and PKB Pathways in Vascular Smooth Muscle Cells
Viktoria Youreva et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2016)
A class of their own: exploring the nondeacetylase roles of class IIa HDACs in cardiovascular disease
Lillianne H. Wright et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2016)
Histone deacetylase and GATA-binding factor 6 regulate arterial remodeling in angiotensin II-induced hypertension
Gwi Ran Kim et al.
JOURNAL OF HYPERTENSION (2016)
Inhibiting cancer cell hallmark features through nuclear export inhibition
Qingxiang Sun et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2016)
Selective Nuclear Export Inhibitor KPT-330 Enhances the Antitumor Activity of Gemcitabine in Human Pancreatic Cancer
Sabiha Kazim et al.
MOLECULAR CANCER THERAPEUTICS (2015)
The critical role of Akt in cardiovascular function
Prasanna Abeyrathna et al.
VASCULAR PHARMACOLOGY (2015)
Histone Deacetylase 4 Controls Neointimal Hyperplasia via Stimulating Proliferation and Migration of Vascular Smooth Muscle Cells
Tatsuya Usui et al.
HYPERTENSION (2014)
Erasers of Histone Acetylation: The Histone Deacetylase Enzymes
Edward Seto et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
Embryonic rat vascular smooth muscle cells revisited - a model for neonatal, neointimal SMC or differentiated vascular stem cells?
Eimear Kennedy et al.
VASCULAR CELL (2014)
Insulin-like growth-factor-1-induced PKB signaling and Egr-1 expression is inhibited by curcumin in A-10 vascular smooth muscle cells
Viktoria Youreva et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2013)
ET-1-induced growth promoting responses involving ERK1/2 and PKB signaling and Egr-1 expression are mediated by Ca2+/CaM-dependent protein kinase-II in vascular smooth muscle cells
Ali Bouallegue et al.
CELL CALCIUM (2013)
Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group
Mercedes Lobera et al.
NATURE CHEMICAL BIOLOGY (2013)
Pathophysiology of Vascular Remodeling in Hypertension
Nicolas F. Renna et al.
INTERNATIONAL JOURNAL OF HYPERTENSION (2013)
MEF2 is regulated by CaMKIIδ2 and a HDAC4-HDAC5 heterodimer in vascular smooth muscle cells
Roman Ginnan et al.
BIOCHEMICAL JOURNAL (2012)
Attenuation of endothelin-1-induced PKB and ERK1/2 signaling, as well as Egr-1 expression, by curcumin in A-10 vascular smooth muscle cells
Georgia Kapakos et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2012)
Nuclear Import of Histone Deacetylase 5 by Requisite Nuclear Localization Signal Phosphorylation
Todd M. Greco et al.
MOLECULAR & CELLULAR PROTEOMICS (2011)
Contribution of epidermal growth factor receptor transactivation in angiotensin II-induced enhanced expression of Gi protein and proliferation in A10 vascular smooth muscle cells
Yessica-Haydee Gomez Sandoval et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2009)
Protein Kinase A-regulated Assembly of a MEF2.HDAC4 Repressor Complex Controls c-Jun Expression in Vascular Smooth Muscle Cells
Joseph W. Gordon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Kruppel-like factor 4, Elk-1, and histone deacetylases cooperatively suppress smooth muscle cell differentiation markers in response to oxidized phospholipids
Tadashi Yoshida et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2008)
Peroxynitrite inhibits the expression of Giα protein and adenylyl cyclase signaling in vascular smooth muscle cells
Marcel Bassil et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Central role of Gq in the hypertrophic signal transduction of angiotensin II in vascular smooth muscle cells
Haruhiko Ohtsu et al.
ENDOCRINOLOGY (2008)
Angiotensin II stimulates protein kinase D-dependent histone deacetylase 5 phosphorylation and nuclear export leading to vascular smooth muscle cell hypertrophy
Xiangbin Xu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Puja K. Mehta et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Akt phosphorylation is essential for nuclear translocation and retention in NGF-stimulated PC12 cells
Truong Le Xuan Nguyen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Early growth response-1 in cardiovascular pathobiology
LM Khachigian
CIRCULATION RESEARCH (2006)
Oxidative stress contributes to the enhanced expression of Giα proteins and adenylyl cyclase signaling in vascular smooth muscle cells from spontaneously hypertensive rats
G Lappas et al.
JOURNAL OF HYPERTENSION (2005)
Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides
A Mai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Class II histone deacetylases:: from sequence to function, regulation, and clinical implication
XJ Yang et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Early growth response-1 promotes atherogenesis - Mice deficient in early growth response-1 and apolipoprotein E display decreased atherosclerosis and vascular inflammation
E Harja et al.
CIRCULATION RESEARCH (2004)
Transactivation of the insulin-like growth factor-I receptor by angiotensin II mediates downstream signaling from the angiotensin II type I receptor to phosphatidylinositol 3-kinase
P Zahradka et al.
ENDOCRINOLOGY (2004)
Arterial smooth muscle cell heterogeneity - Implications for atherosclerosis and restenosis development
HY Hao et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Class II histone deacetylases: versatile regulators
E Verdin et al.
TRENDS IN GENETICS (2003)
The role of angiotensin II in regulating vascular structural and functional changes in hypertension
RM Touyz
CURRENT HYPERTENSION REPORTS (2003)
Vascular remodeling in hypertension - Roles of apoptosis, inflammation, and fibrosis
HD Intengan et al.
HYPERTENSION (2001)
The multiple actions of angiotensin II in atherosclerosis
KM Schmidt-Ott et al.
REGULATORY PEPTIDES (2000)
Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization
CM Grozinger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis
TA McCaffrey et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
